Interferon-alfacon-1 shows efficacy in patients with chronic hepatitis C who have not responded to, or relapsed after, prior therapy with IFN- -2b plus ribavirin

By  

Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Current Antiviral Therapy for Chronic Hepatitis C Including Liver Transplantation and Hepatic Resection

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 2, Iss. 2, 2003-06 ,pp. : 103-111

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the future

By Ferenci Peter  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 529-544

Informa Healthcare

Access to resources Recommend Favorite

Genetic predisposition of responsiveness to therapy for chronic hepatitis C

By Hwang Yuchi   Chen Ellson Y   Gu Z John   Chuang Wan-Long   Yu Ming-Lung   Lai Ming-Yang   Chao You-Chen   Lee Chuan-Mo   Wang Jing-Houng   Dai Chia-Yen   Shian-Jy Bey Monica   Liao Ya-Tang   Chen Pei-Jer   Chen Ding-Shinn  

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 697-709

Future Medicine

Access to resources Recommend Favorite

Chronic hepatitis B and C: update on therapy

By Gonzalez Stevan A   Keeffe Emmet B  

Future Virology, Vol. 4, Iss. 5, 2009-09 ,pp. : 437-452

Future Medicine

Access to resources Recommend Favorite